N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease)
NCT03759665
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
GM2 Gangliosidosis
Tay-Sachs Disease
Sandhoff Disease
Interventions
DRUG:
IB1001
Sponsor
IntraBio Inc